UNCY logo

Unicycive Therapeutics, Inc. (UNCY)

Profile

Full Name

Unicycive Therapeutics, Inc.

Ticker

NASDAQ: UNCY

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 12, 2021

Indexes

Not included

Website

https://unicycive.com

Employees

22

Key Details

Price

$4.62(3.70%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(-100.00% YoY)

Annual EPS

-$5.65(-341.14% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.62
    UNCY price is $4.62

    30-Day Relative Volume

    0.90
    UNCY 30-day relative volume is 0.90

    Price Performance

    Price Most Recent Change

    +3.7%
    UNCY price was up +3.7% on Oct 2, 2025

    Price YTD Change

    -41.81%
    UNCY price is down -41.81% since January 1st

    Price 1-Year Change

    +21.58%
    UNCY price is up +21.58% year-on-year

    Price 3-Year Change

    -23%
    UNCY price is down -23% over the past 3 years

    Price Range

    Price All-Time High

    $87.30
    UNCY price is currently -94.71% below its historical high of $87.30

    Price 3-Year Low

    $2.02
    UNCY price is currently +128.71% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $81.60M
    UNCY market cap is $81.60 million

    Market Cap 3-Year Change

    +801.35%
    UNCY market cap is up +801.35% over the past 3 years

    Market Cap All-Time High

    $108.57M
    UNCY market cap is currently -24.84% below its historical high of $108.57 million

    Market Cap Sector Percentile

    37.54%
    UNCY market cap is higher than 37.54% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +80.48%
    UNCY shares outstanding is up +80.48% year-on-year

    Shares Outstanding 3-Year Change

    +1070.58%
    UNCY shares outstanding is up +1070.58% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.83
    UNCY beta is 0.83

    200-day SMA

    $5.62
    UNCY price is currently -17.81% below its 200-day simple moving average

    50-day SMA

    $4.24
    UNCY price is currently +9.04% above its 50-day simple moving average

    14-Day RSI

    63.97
    UNCY 14-day relative strength index is 63.97

    Volume

    0.90
    UNCY 30-day relative volume is 0.90

    ATR

    $0.25
    UNCY average true range is $0.25

    10-day Historical Volatility

    58.75%
    UNCY 10-day historical volatility is 58.75%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    UNCY annual revenue is $0.00

    Revenue Analysts Estimate

    $590.86K
    UNCY annual revenue is currently -100.00% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    -100%
    UNCY annual revenue is down -100% year-on-year

    Revenue Sector Percentile

    28.76%
    UNCY annual revenue is higher than 28.76% of companies in Healthcare sector

    EPS

    EPS

    -$5.65
    UNCY annual earnings per share is -$5.65

    EPS Analysts Estimate

    -$2.32
    UNCY annual earnings per share is currently +143.79% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -341.14%
    UNCY annual earnings per share is down -341.14% year-on-year

    EPS Sector Percentile

    19.07%
    UNCY annual earnings per share is higher than 19.07% of companies in Healthcare sector

    Profit

    Gross Profit

    -$428.00K
    UNCY annual gross profit is -$428.00 thousand

    Gross Margin

    -
    UNCY annual gross profit margin value is unknown

    Operating Profit

    -$32.12M
    UNCY annual operating income is -$32.12 million

    Operating Margin

    -
    UNCY annual operating profit margin value is unknown

    Net Income

    -$36.73M
    UNCY annual net profit is -$36.73 million

    Net Margin

    -
    UNCY annual net profit margin value is unknown

    Expenses

    Total Expenses

    $36.73M
    UNCY annual total expenses is $36.73 million

    Operating Expenses

    $31.69M
    UNCY annual total operating expenses is $31.69 million

    Cost Of Goods Sold

    $428.00K
    UNCY annual cost of goods sold is $428.00 thousand

    Selling, General & Administrative Expenses

    $0.00
    UNCY annual SG&A is $0.00

    Depreciation & Amortization

    $428.00K
    UNCY annual D&A is $428.00 thousand

    Interest Expense

    $0.00
    UNCY annual interest expense is $0.00

    Income Tax

    $0.00
    UNCY annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$32.12M
    UNCY annual earnings before interest & taxes is -$32.12 million

    EBITDA

    -$31.69M
    UNCY annual EBITDA is -$31.69 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $31.67M
    UNCY annual total assets is $31.67 million

    Non Current Assets

    $720.00K
    UNCY annual long term assets is $720.00 thousand

    Current Assets

    $30.95M
    UNCY annual total current assets is $30.95 million

    Cash and Cash Equivalents

    $26.14M
    UNCY annual cash & cash equivalents is $26.14 million

    Accounts Receivable

    -
    UNCY annual accounts receivable value is unknown

    Inventory

    $0.00
    UNCY annual inventory is $0.00

    Liabilities

    Total Liabilities

    $24.24M
    UNCY annual total liabilities is $24.24 million

    Long Term Liabilities

    $117.00K
    UNCY annual total long term liabilities is $117.00 thousand

    Current Liabilities

    $24.12M
    UNCY annual current liabilities is $24.12 million

    Accounts Payable

    $966.00K
    UNCY annual accounts payable is $966.00 thousand

    Debt

    Total Debt

    $773.00K
    UNCY annual total debt is $773.00 thousand

    Total Debt 1-Year Change

    -4.69%
    UNCY annual total debt is down -4.69% year-on-year

    Long Term Debt

    $117.00K
    UNCY annual long term debt is $117.00 thousand

    Short Term Debt

    $656.00K
    UNCY annual short term debt is $656.00 thousand

    Equity & Capital

    Shareholders Equity

    $7.43M
    UNCY annual stockholders equity is $7.43 million

    Book Value

    $7.43M
    UNCY annual book value is $7.43 million

    Retained Earnings

    -$101.27M
    UNCY annual retained earnings is -$101.27 million

    Working Capital

    $6.83M
    UNCY annual working capital is $6.83 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$28.57M
    UNCY annual cash from operations is -$28.57 million

    Cash From Operations 1-Year Change

    -56.29%
    UNCY annual cash from operations is down -56.29% year-on-year

    Cash From Investing

    -$72.00K
    UNCY annual cash from investing is -$72.00 thousand

    Cash From Investing 1-Year Change

    -500%
    UNCY annual cash from investing is down -500% year-on-year

    Cash From Financing

    $45.09M
    UNCY annual cash from financing is $45.09 million

    Cash From Financing 1-Year Change

    +63.71%
    UNCY annual cash from financing is up +63.71% year-on-year

    CAPEX

    CAPEX

    $72.00K
    UNCY annual capital expenditures is $72.00 thousand

    CAPEX 1-Year Change

    +500%
    UNCY annual capital expenditures is up +500% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$28.65M
    UNCY annual free cash flow is -$28.65 million

    Free Cash Flow 1-Year Change

    -56.58%
    UNCY annual free cash flow is down -56.58% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    UNCY annual gross profit margin value is unknown

    Operating Margin

    -
    UNCY annual operating profit margin value is unknown

    Net Margin

    -
    UNCY annual net profit margin value is unknown

    ROA & ROE

    ROA

    -160.18%
    UNCY annual return on assets is -160.18%

    ROE

    -2028.11%
    UNCY annual return on equity is -2028.11%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    UNCY price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    UNCY price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    4.97
    UNCY price to book ratio is 4.97

    PB Ratio Sector Percentile

    77.05%
    UNCY price to book ratio is higher than 77.05% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    UNCY price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    UNCY price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $59.68M
    UNCY enterprise value is $59.68 million

    Enterprise Value Sector Percentile

    39.08%
    UNCY enterprise value is higher than 39.08% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.99
    UNCY EV/EBITDA is -1.99

    EV/EBITDA Sector Percentile

    38.88%
    UNCY EV/EBITDA is higher than 38.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    1.28
    UNCY annual current ratio is 1.28

    Quick Ratio

    1.28
    UNCY annual quick ratio is 1.28

    Leverage

    Debt To Equity

    0.10
    UNCY annual debt to equity ratio is 0.10

    Interest Coverage Ratio

    -
    UNCY annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    UNCY piotroski f-score value is unknown

    Altman Z-Score

    -5.55
    UNCY altman z-score is -5.55

    Analyst ratings

    Recent major analysts updates

    Sep 15, 25 Benchmark
    Speculative Buy
    Apr 21, 25 Guggenheim
    Buy
    Apr 11, 25 HC Wainwright & Co.
    Buy
    Apr 1, 25 HC Wainwright & Co.
    Buy
    Jan 29, 25 HC Wainwright & Co.
    Buy
    Jan 8, 25 HC Wainwright & Co.
    Buy
    Nov 22, 24 Benchmark
    Speculative Buy
    Nov 14, 24 HC Wainwright & Co.
    Buy
    Nov 12, 24 HC Wainwright & Co.
    Buy
    Oct 9, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with UNCY included

    Growing Shares Outstanding
    US stocks
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Unicycive Therapeutics, Inc.?
    • Does Unicycive Therapeutics, Inc. pay dividends?
    • What sector is Unicycive Therapeutics, Inc. in?
    • What industry is Unicycive Therapeutics, Inc. in?
    • What country is Unicycive Therapeutics, Inc. based in?
    • When did Unicycive Therapeutics, Inc. go public?
    • Is Unicycive Therapeutics, Inc. in the S&P 500?
    • Is Unicycive Therapeutics, Inc. in the NASDAQ 100?
    • Is Unicycive Therapeutics, Inc. in the Dow Jones?
    • When was Unicycive Therapeutics, Inc.'s last earnings report?
    • When does Unicycive Therapeutics, Inc. report earnings?

    What is the ticker symbol for Unicycive Therapeutics, Inc.?

    The ticker symbol for Unicycive Therapeutics, Inc. is NASDAQ:UNCY

    Does Unicycive Therapeutics, Inc. pay dividends?

    No, Unicycive Therapeutics, Inc. does not pay dividends

    What sector is Unicycive Therapeutics, Inc. in?

    Unicycive Therapeutics, Inc. is in the Healthcare sector

    What industry is Unicycive Therapeutics, Inc. in?

    Unicycive Therapeutics, Inc. is in the Biotechnology industry

    What country is Unicycive Therapeutics, Inc. based in?

    Unicycive Therapeutics, Inc. is headquartered in United States

    When did Unicycive Therapeutics, Inc. go public?

    Unicycive Therapeutics, Inc.'s initial public offering (IPO) was on July 12, 2021

    Is Unicycive Therapeutics, Inc. in the S&P 500?

    No, Unicycive Therapeutics, Inc. is not included in the S&P 500 index

    Is Unicycive Therapeutics, Inc. in the NASDAQ 100?

    No, Unicycive Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Unicycive Therapeutics, Inc. in the Dow Jones?

    No, Unicycive Therapeutics, Inc. is not included in the Dow Jones index

    When was Unicycive Therapeutics, Inc.'s last earnings report?

    Unicycive Therapeutics, Inc.'s most recent earnings report was on August 14, 2025

    When does Unicycive Therapeutics, Inc. report earnings?

    The date for Unicycive Therapeutics, Inc.'s next earnings report has not been announced yet
    On this page